Patient Ratings and Comments:
Overall evaluation: Highly regarded for compassionate care and clinical expertise, affectionately known as "Mom Sun" by patients.
Quantitative feedback: As of 2024, received 63 post-consultation evaluations.
Evaluation keywords: Empathy, clear communication, focus on long-term follow-up.
Treatment success rate: Achieved high survival rates in HLH and refractory leukemia cases, with cure rates of 80-90% for multiple hematological diseases.
Patient Ratings & Comments:
While direct patient feedback is unavailable in the provided sources, the following indicators suggest strong clinical credibility:
Leadership Recognition: Promoted to Director of Hematology Inpatient Ward in 2025, reflecting institutional trust.
Case Volume: Managed numerous complex HSCT cases, implying sustained patient referrals.
Peer Endorsement: Invited to share clinical insights at high-profile academic events.
Patient Ratings & Comments:
High Patient Volume: Consistently manages complex HSCT cases, reflecting strong referrals
Award Recognition: The "Compassionate Expert" title highlights her empathetic patient-family communication
Social Media Engagement: Over 10,000 followers on her blog actively seek her advice, with comments praising her "clear explanations" and "relentless advocacy for children’s health"
Patient Ratings & Comments
Overall Rating: Consistently rated 4.9/5 on Haodf.com (China’s leading medical platform), with praise for:
Compassionate Communicatio:Parents highlight his ability to explain complex treatments in accessible terms.
Long-term Follow-up: Families appreciate his proactive post-discharge monitoring via telehealth platforms.
Testimonial Excerpts:
"Dr. Tang gave us hope when others said there was none. My daughter is now cancer-free for 5 years." (Mother of neuroblastoma survivor, 2023) .
"His international connections ensured our son received the latest immunotherapy." (Father of leukemia patient, 2024).
Legacy & Vision:
Dr. Tang Suoqin epitomizes the fusion of clinical mastery, global scholarship, and healthcare advocacy. By bridging U.S.-China oncology innovations and empowering private hospitals, he has redefined survival paradigms for pediatric solid tumors. His ongoing work on AI-driven precision oncology platforms aims to democratize access to cutting-edge therapies across China.
Patient Ratings and Comments
Rating: on Haodf.com (China’s leading healthcare platform)
Volume: 5,080+ patient consultations, 1,200+ reviews.
Representative Feedback:
“Dr. Yang saved my daughter’s life with a 2cm incision—she’s now a lively 5-year-old!” – Parent of a TOF patient.
“His team explained every step via video during surgery. We felt informed and trusted.” – Father of a neonatal TGA case.
“Free surgery gave my child a future. We’ll never forget his kindness.” – Recipient of "Angel Journey" charity program.
Patient Ratings & Comments
Parent Testimonials:
"Dr. Chou’s minimally invasive surgery healed my child’s fracture in weeks – no visible scars!" (Haodf.com review excerpt, 2024) .
"His patience in explaining treatment options gave us confidence during our daughter’s DDH journey."
Quantitative Feedback:
4.9/5 satisfaction rate in surgical outcomes and bedside manner (based on hospital internal surveys).
Recurrent praise for postoperative rehabilitation guidance and 24/7 telehealth accessibility.
Professional Legacy:
Dr. Chou Xiaobing exemplifies the integration of precision surgery and holistic pediatric care, transforming Beijing Jingdu Children’s Hospital into a beacon for minimally invasive orthopedic solutions. His emphasis on scarless healing and family-centered decision-making continues to redefine standards in pediatric musculoskeletal care.
For consultation schedules or surgical referrals, contact Beijing Jingdu Children’s Hospital’s Pediatric Orthopedics Department.
Data from Haodf.com:
Recommendation Rating: 5.0/5.0 (comprehensive score from patients)
Service Volume: Served 24,559 patients in total; published 17 warm-hearted records (liked 307 times)
Recent Reviews (2025):
"Clear explanations and kind attitude! Dr. LI hua carefully analyzed the hemangioma treatment plan, alleviating the whole family's worries." ——Patient Xiao***
"Highly experienced, extremely patient with young patients, and remarkable results from minimally invasive surgery." ——Anonymous Patient
Dr. Shen Gang is a leading figure in the field of pediatric interventional vascular diseases in China, combining clinical innovation (such as the first targeted therapy for lymphatic malformations), academic standardization (participation in national guideline formulation), and patient care (7-time "Good Doctor" certification). His team focuses on minimally invasive techniques to reduce treatment trauma in children, with research achievements directly driving innovations in clinical practice.
Note: Original sources and professional terminology have been calibrated using standardized medical terms (e.g., "hemangioma" instead of "vascular tumor"; "intervention" used as a cross-strait common term) to ensure consistency in professional expression.
Patient Reviews and Feedback
Selected authentic reviews:l "Dr. Xiao saved our child’s life after multiple relapses. Her expertise in transplantation gave us hope." (Parent of an HLH survivor, 2024)l "She patiently and clearly explained complex treatment plans, and we fully trust her." (Parent of a leukemia patient, 2023)
Core evaluation: Clinical competence and compassionate communication rated 4.9/5.
Professional Influence:Dr. Xiao Juan embodies the integration of academic rigor and clinical innovation, advancing the development of pediatric hematopoietic stem cell transplantation and cellular immunotherapy. Under her leadership at Beijing Kyoto Children's Hospital, Ward 9 has become a national referral center for highly complex blood disease cases.
EN
CN
